Condition: Gastroesophageal Reflux in Children · Sponsor: United Pharmaceuticals
The aim of the study is to assess the effectiveness of this new formula on regurgitations and secondarily its effect on digestive tolerance through a randomized, controlled, double-blind trial against a comparator.
This description comes directly from the study's public registry record.
Magalie JEGAT · +330155372222 · m.jegat@novalac.com
ANNE-SOPHIE GARREAU · as.garreau@novalac.com
Always discuss trial participation with your own doctor first.
| Center_14 | Namur, Belgium | Active Not Recruiting |
| Center_15 | Thuin, Belgium | Recruiting |
| Center_09 | Castelnau-le-Lez, France | Active Not Recruiting |
| Center_02 | Étampes, France | Recruiting |
| Center_05 | Libourne, France | Recruiting |
| Centre_10 | Maromme, France | Recruiting |
| Center_16 | Nice, France | Recruiting |
| Center_08 | Vincennes, France | Recruiting |
| Center_01 | Athens, Greece | Recruiting |
| Center_11 | Thessaloniki, Greece | Recruiting |
| Center_12 | Naples, Italy | Recruiting |
| Center_13 | Naples, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04358146